Related Experiment Video
Updated: Jan 11, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
Alzheimer's Disease Risk Prediction and Pathogeny Extraction Using Fuzzy Graph Evolutionary Generative Adversarial
None:
Timely risk prediction of Alzheimer's disease (AD) holds significant clinical value. However, the inherent fuzziness of disease information hinders the deeper understanding of AD pathogenesis and limits the effectiveness of current predictive models. This article explores the staged evolutionary patterns of AD by integrating fuzzy graph-based disease modeling and deep learning. First, we use fuzzy graphs to quantify interpathogeny associations through fuzzy memberships. Second, we propose a fuzzy entropy propagation model to mathematically describe AD deterioration as the spread of fuzzy entropy information in fuzzy graphs. Finally, we introduce a novel fuzzy graph evolutionary generative adversarial network (FGE-GAN) for disease risk prediction and pathogeny extraction. In the generator of FGE-GAN, fuzzy graph convolution (FGC) layers are designed based on the mathematical model to capture AD's evolutionary patterns with interpretability. Experiments on multiple brain disease datasets indicate that FGE-GAN outperforms state-of-the-art methods in disease risk prediction. In addition, the extracted multiomics pathogenies provide valuable insights for early intervention. The code is available at: github.com/fmri123456/FGE-GAN.
More Related Videos
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Dementia
The progression of dementia is generally gradual....